Annual Interest Expense
$37.42 M
+$13.60 M+57.08%
December 31, 2024
Summary
- As of February 23, 2025, KPTI annual interest expense is $37.42 million, with the most recent change of +$13.60 million (+57.08%) on December 31, 2024.
- During the last 3 years, KPTI annual interest expense has risen by +$11.38 million (+43.68%).
- KPTI annual interest expense is now at all-time high.
Performance
KPTI Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Interest Expense
N/A
December 31, 2024
Summary
- KPTI quarterly interest expense is not available.
Performance
KPTI Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM Interest Expense
N/A
December 31, 2024
Summary
- KPTI TTM interest expense is not available.
Performance
KPTI TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Interest Expense Formula
Interest Expense = Carrying Value of Debt X Effective Interest Rate
KPTI Interest Expense Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +57.1% | - | - |
| 3 y3 years | +43.7% | - | - |
| 5 y5 years | +139.2% | - | - |
KPTI Interest Expense Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +57.1% | ||||
| 5 y | 5-year | at high | +139.2% | ||||
| alltime | all time | at high | -100.0% |
Karyopharm Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $37.42 M(+57.1%) | - | - |
| Sep 2024 | - | $11.38 M(+27.2%) | $32.43 M(+19.6%) |
| Jun 2024 | - | $8.95 M(+52.1%) | $27.11 M(+13.2%) |
| Mar 2024 | - | $5.88 M(-5.2%) | $23.95 M(+0.5%) |
| Dec 2023 | $23.82 M(-4.7%) | $6.21 M(+2.2%) | $23.82 M(+1.4%) |
| Sep 2023 | - | $6.07 M(+5.0%) | $23.50 M(-0.2%) |
| Jun 2023 | - | $5.78 M(+0.5%) | $23.54 M(-2.2%) |
| Mar 2023 | - | $5.76 M(-2.2%) | $24.07 M(-3.7%) |
| Dec 2022 | $25.00 M(-4.0%) | $5.88 M(-3.7%) | $25.00 M(-7.6%) |
| Sep 2022 | - | $6.11 M(-3.2%) | $27.05 M(-6.5%) |
| Jun 2022 | - | $6.31 M(-5.6%) | $28.95 M(+4.7%) |
| Mar 2022 | - | $6.68 M(-15.8%) | $27.64 M(+6.1%) |
| Dec 2021 | $26.05 M(-4.0%) | $7.94 M(-0.9%) | $26.05 M(+3.4%) |
| Sep 2021 | - | $8.01 M(+60.2%) | $25.18 M(+5.0%) |
| Jun 2021 | - | $5.00 M(-1.8%) | $23.97 M(-6.8%) |
| Mar 2021 | - | $5.09 M(-28.0%) | $25.73 M(-5.2%) |
| Dec 2020 | $27.14 M | $7.07 M(+4.0%) | $27.14 M(+2.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2020 | - | $6.80 M(+0.6%) | $26.54 M(+16.2%) |
| Jun 2020 | - | $6.76 M(+3.8%) | $22.83 M(+19.2%) |
| Mar 2020 | - | $6.51 M(+0.6%) | $19.16 M(+22.4%) |
| Dec 2019 | $15.65 M(+527.6%) | $6.47 M(+109.1%) | $15.65 M(+34.0%) |
| Sep 2019 | - | $3.09 M(+0.1%) | $11.67 M(+36.0%) |
| Jun 2019 | - | $3.09 M(+3.0%) | $8.58 M(+56.3%) |
| Mar 2019 | - | $3.00 M(+20.3%) | $5.49 M(+120.3%) |
| Dec 2018 | $2.49 M(>+9900.0%) | $2.49 M(>+9900.0%) | $2.49 M(>+9900.0%) |
| Sep 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 2018 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 2017 | $0.00(0.0%) | - | - |
| Dec 2016 | $0.00(-100.0%) | - | - |
| Dec 2014 | $1000.00(>+9900.0%) | - | - |
| Dec 2013 | $0.00(0.0%) | - | - |
| Dec 2012 | $0.00(0.0%) | $0.00(0.0%) | $0.00(0.0%) |
| Sep 2012 | - | $0.00 | $0.00 |
| Dec 2011 | $0.00 | - | - |
FAQ
- What is Karyopharm Therapeutics annual interest expense?
- What is the all time high annual interest expense for Karyopharm Therapeutics?
- What is Karyopharm Therapeutics annual interest expense year-on-year change?
- What is the all time high quarterly interest expense for Karyopharm Therapeutics?
- What is the all time high TTM interest expense for Karyopharm Therapeutics?
What is Karyopharm Therapeutics annual interest expense?
The current annual interest expense of KPTI is $37.42 M
What is the all time high annual interest expense for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high annual interest expense is $37.42 M
What is Karyopharm Therapeutics annual interest expense year-on-year change?
Over the past year, KPTI annual interest expense has changed by +$13.60 M (+57.08%)
What is the all time high quarterly interest expense for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high quarterly interest expense is $11.38 M
What is the all time high TTM interest expense for Karyopharm Therapeutics?
Karyopharm Therapeutics all-time high TTM interest expense is $32.43 M